𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advanced ovarian carcinoma: Response to antiestrogen therapy

✍ Scribed by Adam M. Myers; George E. Moore; Francis J. Major

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
356 KB
Volume
48
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hexamethylmelamine and melphalan as salv
Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma
✍ Margaret A. Tempero; Anne Kessinger πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 206 KB

## Abstract Ten patients with advanced ovarian carcinoma were treated with hexa‐methylmelamine and melphalan after failing first‐line combination chemotherapy. In eight patients residual disease was evident only at second‐look laparotomy. Surgical debulking was accomplished in four patients but onl

Continued chemotherapy after complete re
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer : A meta-analysis
✍ Lisa M. Hess; Nan Rong; Patrick O. Monahan; Paridha Gupta; Champ Thomaskutty; Da πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 552 KB

## Abstract ## BACKGROUND. Ovarian cancer (OC) is associated with a >75% risk of recurrence after completion of primary therapy. Several clinical trials have explored the role of continued therapy after complete response to primary adjuvant therapy to reduce the risk of recurrence; however, these

Intraperitoneal bispecific antibody (HEA
Intraperitoneal bispecific antibody (HEA125xOKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma
✍ Alexander MarmΓ©; Gudrun Strauß; Gunther Bastert; Eva-Maria Grischke; Gerhard Mol πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 135 KB

Bispecific antibody HEA125 x OKT3 was shown to redirect T lymphocytes toward carcinoma cells and to induce tumor cell lysis in vitro. Preclinical studies have demonstrated that tumor-associated lymphocytes (TAL) derived from malignant ascites can be used as effector cells with a high efficacy and wi